FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

US Agency Releases Startling Report on Anti-Christian Persecution in Major Islamic Country

Inside the US military playbook to cripple Iran if nuclear talks collapse

Spain readies for evacuations as a hantavirus-hit cruise ship heads for the Canary Islands

California abortion pill suppliers plot workarounds ahead of Supreme Court mifepristone decision

Accused street takeover mastermind charged after wild stunts, machine gun chaos: police

Catfish Farmers, Undertakers, Miners Celebrate Major Trump Admin EPA Deregulation

Connecticut pro-Second Amendment group sounds alarm on Glock-style ban, fear Democrats will go even further

California professor accused of killing pro-Israel protester will ‘likely’ avoid lengthy prison sentence

Watch As Democrat Xavier Becerra Calls Migrant Kids Lost Under His Watch MAGA Talking Point

LGBTQ ‘lavender graduations’ set to take place at major Christian colleges, including one with a drag show

Fact Check: No, Kash Patel Is Not Having Custom Bourbon Made on the FBI’s Dime

All gas, no brakes: Wild moments in Trumpworld this week that captured attention

Trump throws his base a UFO bone, but critics say it’s Iran ‘smoke and mirrors’

Two-party politics ‘dead and buried’ in UK after local election bloodbath

Democrats shy away from questions on whether Harris should run for president in 2028

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”